​

Bionano Genomics Ownership | Who Owns Bionano Genomics?

OverviewForecastRevenueFinancialsChartTranscripts

Bionano Genomics Ownership Summary

Bionano Genomics is owned by 17.39% institutional investors, and 82.61% retail investors. Geode capital management is the largest institutional shareholder, holding 0% of BNGO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.78% of its assets in Bionano Genomics shares.

BNGO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockBionano Genomics17.39%-82.61%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryDiagnostics & Research Stocks49.06%8.59%42.35%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Geode capital management---
Credit agricole s a---
Aviso financial---
Inspire advisors---
Td waterhouse canada---
Advisor group---
Jane street group---
Modus advisors---
Fifth third bancorp---
Gps wealth strategies group---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Geode capital management---
Credit agricole s a---
Aviso financial---
Inspire advisors---
Td waterhouse canada---
Advisor group---
Jane street group---
Modus advisors---
Fifth third bancorp---
Gps wealth strategies group---

Top Buyers

HolderShares% AssetsChange
Compagnie lombard odier scma---20.00
Fifth third bancorp---71.00
Aviso financial---102.00
Modus advisors---122.00
Pnc financial services group---127.00

Top Sellers

HolderShares% AssetsChange
Vanguard group---1.88M
Geode capital management---997.68K
Blackrock funding, inc. /de---606.41K
Jane street group---410.47K
Xtx topco---157.28K

Sold Out

HolderChange
Compagnie lombard odier scma-20.00
Fifth third bancorp-71.00
Aviso financial-102.00
Modus advisors-122.00
Pnc financial services group-127.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2023124-8.82%52,518,841-35.69%172.38%49-15.52%4110.81%
Mar 31, 2023136-15.00%81,658,867-1.17%273.31%58-30.95%37-
Dec 31, 20221605.96%82,622,3413.41%283.76%8452.73%37-13.95%
Sep 30, 2022151-0.66%79,897,646-2.91%273.32%55-3.51%43-4.44%
Jun 30, 2022152-6.75%82,295,90113.14%284.41%57-17.39%45-13.46%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv41.39K1.78%-12.23K
Vanguard US Total Market Shares ETF1.36M0.98%-1.00
Fidelity Extended Market Index9.89K0.42%-10.83K
Vanguard Institutional Extnd Mkt Idx Tr8.42K0.36%-
Vanguard Health Care ETF311.67K0.33%-704.00
BlackRock Extended Equity Market K193.76K0.23%-82.00
Fidelity Total Market Index2.77K0.12%-
Extended Equity Market Fund K3.19K0.11%9.00
Fidelity Series Total Market Index2.38K0.10%115.00
Spartan Extended Market Index Pool F1.37K0.06%131.00

Insider Transactions Trends

DateBuySell
2024 Q4--
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q3--

BNGO Ownership FAQ

Who Owns Bionano Genomics?

Bionano Genomics shareholders are primarily institutional investors at 17.39%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Bionano Genomics's industry, Diagnostics & Research Stocks, is 49.06%, which Bionano Genomics falls below.

Who owns the most shares of Bionano Genomics?

Bionano Genomics’s largest shareholders are Geode capital management (0 shares, 0%), Credit agricole s a (0 shares, 0%), and Aviso financial (0 shares, 0%). Together, they hold 0% of Bionano Genomics’s total shares outstanding.

Does Blackrock own Bionano Genomics?

BlackRock is not among the top 10 institutional shareholders of Bionano Genomics.

Who is Bionano Genomics’s biggest shareholder by percentage of total assets invested?

Geode capital management is Bionano Genomics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Bionano Genomics shares, valued at 0$.

Who is the top mutual fund holder of Bionano Genomics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Bionano Genomics shares, with 1.78% of its total shares outstanding invested in 41.39K Bionano Genomics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools